Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3526 AL 3540

Deep brain stimulation and oropharyngeal dysfunction in Parkinson's disease: a case report

Termsarasab P, Tse W.

Parkinsonism Relat Disord. 2015 Jan;21(1):79-80. doi: 10.1016/j.parkreldis.2014.10.019. Epub 2014 Nov 1.

Resolution of stress induced reversible myocardial SPECT defect in Wolf Parkinson White (WPW) syndrome

Gerbay A, Vola M, Terreaux J, Steiner-Emptaz A, Da Costa A, Isaaz K.

Int J Cardiol. 2015 Jan 20;179:489-90. doi: 10.1016/j.ijcard.2014.11.051. Epub 2014 Nov 6.

Postural instability, the absence of sexual intercourse in the past month, and loss of libido are predictors of sexual dysfunction in Parkinson's disease

Jitkritsadakul O, Jagota P, Bhidayasiri R.

Parkinsonism Relat Disord. 2015 Jan;21(1):61-7. doi: 10.1016/j.parkreldis.2014.11.003. Epub 2014 Nov 12.

Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale

Martínez-Martín P, Rodríguez-Blázquez C, Mario Alvarez, Arakaki T, Arillo VC, Chaná P, Fernández W, Garretto N, Martínez-Castrillo JC, Rodríguez-Violante M, Serrano-Dueñas M, Ballesteros D, Rojo-Abuin JM, Chaudhuri KR, Merello M.

Parkinsonism Relat Disord. 2015 Jan;21(1):50-4. doi: 10.1016/j.parkreldis.2014.10.026. Epub 2014 Nov 5.

Gait and attentional performance in freezers under methylphenidate

Delval A, Moreau C, Bleuse S, Guehl D, Bestaven E, Guillaud E, Dujardin K, Defebvre L, Devos D.

Gait Posture. 2015 Feb;41(2):384-8. doi: 10.1016/j.gaitpost.2014.10.022. Epub 2014 Oct 30.

Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic

Wight S, Miller N.

Int J Lang Commun Disord. 2015 Mar-Apr;50(2):215-25. doi: 10.1111/1460-6984.12132. Epub 2014 Dec 3.

Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease

Napier TC, Corvol JC, Grace AA, Roitman JD, Rowe J, Voon V, Strafella AP.

Mov Disord. 2015 Feb;30(2):141-9. doi: 10.1002/mds.26068. Epub 2014 Dec 5.

Molecular imaging in genetics

Leite J, Hespanhol R, Buchpiguel CA.

Neuroimaging Clin N Am. 2015 Feb;25(1):17-29. doi: 10.1016/j.nic.2014.09.005. Epub 2014 Oct 18.

Novel formulations and modes of delivery of levodopa

Poewe W, Antonini A.

Mov Disord. 2015 Jan;30(1):114-20. doi: 10.1002/mds.26078. Epub 2014 Dec 5.

Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease

Pilleri M, Antonini A.

Expert Opin Drug Saf. 2015 Feb;14(2):281-94. doi: 10.1517/14740338.2015.988137. Epub 2014 Dec 6.

Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage

Peluso S, De Rosa A, Antenora A, Lieto M, Criscuolo C, Barbieri F, Pappatà S, De Michele G.

Parkinsonism Relat Disord. 2015 Feb;21(2):156-8. doi: 10.1016/j.parkreldis.2014.10.029. Epub 2014 Nov 21.

Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation

Shao N, Yang J, Shang H.

Neurosci Lett. 2015 Feb 5;587:79-86. doi: 10.1016/j.neulet.2014.12.007. Epub 2014 Dec 5.

Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease

Fuxe K, Guidolin D, Agnati LF, Borroto-Escuela DO.

Expert Opin Ther Targets. 2015 Mar;19(3):377-98. doi: 10.1517/14728222.2014.981529. Epub 2014 Dec 8.

Disturbed mitochondrial dynamics and neurodegenerative disorders

Burté F, Carelli V, Chinnery PF, Yu-Wai-Man P.

Nat Rev Neurol. 2015 Jan;11(1):11-24. doi: 10.1038/nrneurol.2014.228. Epub 2014 Dec 9.

Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)

Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G.

Mov Disord. 2015 Apr 15;30(5):646-54. doi: 10.1002/mds.26086. Epub 2014 Dec 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias